This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dufayet de la Tour, D. Articles by Levine, F. Search for Related Content PubMed PubMed Citation Articles by Dufayet de la Tour, D. Articles by Levine, F.

ß-Cell Differentiation from a Human Pancreatic Cell Line in Vitro and in Vivo

University of California San Diego Cancer Center La Jolla, California 92093-0912

Cell transplantation therapy for diabetes is limited by an inadequate supply of cells exhibiting glucose-responsive insulin secretion. To generate an unlimited supply of human ß-cells, inducibly transformed pancreatic ß-cell lines have been created by expression of dominant oncogenes. The cell lines grow indefinitely but lose differentiated function. Induction of ß-cell differentiation was achieved by stimulating the signaling pathways downstream of the transcription factor PDX-1, cell-cell contact, and the glucagon-like peptide (GLP-1) receptor. Synergistic activation of those pathways resulted in differentiation into functional ß-cells exhibiting glucose-responsive insulin secretion in vitro. Both oncogene-expressing and oncogene-deleted cells were transplanted into nude mice and found to exhibit glucose-responsive insulin secretion in vivo. The ability to grow unlimited quantities of human ß-cells is a major step toward developing a cell transplantation therapy for diabetes.

This article has been cited by other articles:

				J. C. Schisler, P. T. Fueger, D. A. Babu, H. E. Hohmeier, J. S. Tessem, D. Lu, T. C. Becker, B. Naziruddin, M. Levy, R. G. Mirmira, et al. Stimulation of Human and Rat Islet {beta}-Cell Proliferation with Retention of Function by the Homeodomain Transcription Factor Nkx6.1 Mol. Cell. Biol., May 15, 2008; 28(10): 3465 - 3476. [Abstract] [Full Text] [PDF]

				K.-H. Yew, K. L. Prasadan, B. L. Preuett, M. J. Hembree, C. R. McFall, C. L. Benjes, A. R. Crowley, S. L. Sharp, Z. Li, S. S. Tulachan, et al. Interplay of Glucagon-Like Peptide-1 and Transforming Growth Factor-{beta} Signaling in Insulin-Positive Differentiation of AR42J Cells Diabetes, November 1, 2004; 53(11): 2824 - 2835. [Abstract] [Full Text] [PDF]

				J. F. List and J. F. Habener Glucagon-like peptide 1 agonists and the development and growth of pancreatic {beta}-cells Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E875 - E881. [Abstract] [Full Text] [PDF]

				S. EFRAT Regulation of Insulin Secretion: Insights from Engineered {beta}-cell Lines Ann. N.Y. Acad. Sci., April 1, 2004; 1014(1): 88 - 96. [Abstract] [Full Text] [PDF]

				R. P. Robertson Islet Transplantation as a Treatment for Diabetes -- A Work in Progress N. Engl. J. Med., February 12, 2004; 350(7): 694 - 705. [Full Text] [PDF]

				T. Okitsu, N. Kobayashi, H.-S. Jun, S. Shin, S.-J. Kim, J. Han, H. Kwon, M. Sakaguchi, T. Totsugawa, M. Kohara, et al. Transplantation of Reversibly Immortalized Insulin-Secreting Human Hepatocytes Controls Diabetes in Pancreatectomized Pigs Diabetes, January 1, 2004; 53(1): 105 - 112. [Abstract] [Full Text] [PDF]

				D. J. Drucker Glucagon-Like Peptide-1 and the Islet {beta}-Cell: Augmentation of Cell Proliferation and Inhibition of Apoptosis Endocrinology, December 1, 2003; 144(12): 5145 - 5148. [Full Text] [PDF]

				L. Farilla, A. Bulotta, B. Hirshberg, S. Li Calzi, N. Khoury, H. Noushmehr, C. Bertolotto, U. Di Mario, D. M. Harlan, and R. Perfetti Glucagon-Like Peptide 1 Inhibits Cell Apoptosis and Improves Glucose Responsiveness of Freshly Isolated Human Islets Endocrinology, December 1, 2003; 144(12): 5149 - 5158. [Abstract] [Full Text] [PDF]

				P. ITKIN-ANSARI, I. GERON, E. HAO, C. DEMETERCO, B. TYRBERG, and F. LEVINE Cell-Based Therapies for Diabetes: Progress towards a Transplantable Human {beta} Cell Line Ann. N.Y. Acad. Sci., November 1, 2003; 1005(1): 138 - 147. [Abstract] [Full Text] [PDF]

				M. Zalzman, S. Gupta, R. K. Giri, I. Berkovich, B. S. Sappal, O. Karnieli, M. A. Zern, N. Fleischer, and S. Efrat Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells PNAS, June 10, 2003; 100(12): 7253 - 7258. [Abstract] [Full Text] [PDF]

				D. J. Drucker Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis Mol. Endocrinol., February 1, 2003; 17(2): 161 - 171. [Abstract] [Full Text] [PDF]

				Y. Li, T. Hansotia, B. Yusta, F. Ris, P. A. Halban, and D. J. Drucker Glucagon-like Peptide-1 Receptor Signaling Modulates beta Cell Apoptosis J. Biol. Chem., January 3, 2003; 278(1): 471 - 478. [Abstract] [Full Text] [PDF]

				C. Demeterco, P. Itkin-Ansari, B. Tyrberg, L. P. Ford, R. A. Jarvis, and F. Levine c-Myc Controls Proliferation Versus Differentiation in Human Pancreatic Endocrine Cells J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3475 - 3485. [Abstract] [Full Text] [PDF]

				H.-p. Huang, K. Chu, E. Nemoz-Gaillard, D. Elberg, and M.-J. Tsai Neogenesis of {beta}-Cells in Adult BETA2/NeuroD-Deficient Mice Mol. Endocrinol., March 1, 2002; 16(3): 541 - 551. [Abstract] [Full Text] [PDF]

				J. OBERHOLZER, C. TOSO, F. RIS, P. BUCHER, F. TRIPONEZ, A. DEMIRAG, J. LOU, and P. MOREL {beta} Cell Replacement for the Treatment of Diabetes Ann. N.Y. Acad. Sci., November 1, 2001; 944(1): 373 - 387. [Abstract] [Full Text] [PDF]